Hidradenitis Suppurativa (HS)

An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

Adalimumab-psoriasis and Small Bowel Lesions

REstore Working Ability in RheumatoiD Arthritis

Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa

Efficacy Study of Adalimumab to Treat Interstitial Cystitis

Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)

Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis

Remission in Subjects With Crohn's Disease, Open Label Extension

Long Term Open Label Continuation Study

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

Adalimumab in Adult Japanese Subjects With Psoriasis

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

D2E7-Early AS

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

A Study With CIT-013 in HS Patients

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa

A Study of Adalimumab to Treat Sarcoidosis of the Skin

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis